LeAP
- United States
Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-19
Charlotte, N.C., United States: Topline clinical trial results showed LEUKINE® was safe, well tolerated and generated T cells targeted at…
Read More »